University of California San Francisco

Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata. (35364216)

King B, Mesinkovska N, Mirmirani P, Bruce S, Kempers S, Guttman-Yassky E, Roberts JL, McMichael A, Colavincenzo M, Hamilton C, Braman V, Cassella JV PMID: 35364216

Disparities in access for melanoma screening by region, specialty, and insurance: A cross-sectional audit study. (35373156)

Cortez JL, Fadadu RP, Konda S, Grimes B, Wei ML PMID: 35373156

Challenges for dermatologists during the COVID-19 pandemic: A qualitative study. (35620026)

Helm MF, Kimball AB, Butt M, Stuckey H, Costigan H, Shinkai K, Nagler AR PMID: 35620026

Percutaneous egression: What do we know? (35325893)

Sun Q, Purvis CG, Iqbal SN, Emmerich VK, Feldman SR, Maibach H PMID: 35325893

A review of the efficacy of easily accessible dry decontaminants for human chemical contamination. (35275408)

Nandamuri S, Feschuk AM, Maibach HI PMID: 35275408

Transforming growth factor-β1 in regulatory T cell biology. (35302863)

Moreau JM, Velegraki M, Bolyard C, Rosenblum MD, Li Z PMID: 35302863

Solitary cutaneous infantile myofibroma as a hallmark of myofibromatosis: Two cases and review of the literature. (35297087)

Braun M, Pascual M, Mully T, Phelps A, Prok L, Shah SD, Kohn LL PMID: 35297087

Multiomic Analysis of the Gut Microbiome in Psoriasis Reveals Distinct Host‒Microbe Associations. (35757783)

Chang HW, Yan D, Singh R, Bui A, Lee K, Truong A, Milush JM, Somsouk M, Liao W PMID: 35757783

Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors. (35262628)

Jiang H, Muir RK, Gonciarz RL, Olshen AB, Yeh I, Hann BC, Zhao N, Wang YH, Behr SC, Korkola JE, Evans MJ, Collisson EA, Renslo AR PMID: 35262628

Geographic practice preferences of graduating medical students pursuing careers in dermatology. (35276287)

Fulk T, Wessman LL, Gupta R, Brodell RT, Farah RS, Smith CF, Gaddis KJ, Mansh M PMID: 35276287